2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
20
Neoplasms
19
Cancer Pain
16
Pain, Postoperative
12
Agnosia
8
Chronic Pain
7
Breast Neoplasms
5
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Multiple Myeloma
3
Mucositis
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Wounds and Injuries
2
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Supratentorial Neoplasms
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Interventions
Morphine
1
Levobupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sigmoidal Tumour
×
Morphine
×
Clear all
NCT01825993
2013-04-08
2013/004
Corporacion Parc Tauli
Phase 3
Unknown
225 enrolled